A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines

A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines

BackgroundCurrently, data on long-term immune responses to a homogenous booster dose of the inactivated COVID-19 vaccine are still limited among people living with HIV (PLWH).MethodsA prospective cohort study with a 13-month follow-up was conducted in China between March 2021 and August 2022 to eval...

Full description

Bibliographic Details
Main Authors:	Yuting Tan, Shi Zou, Fangzhao Ming, Songjie Wu, Wei Guo, Mengmeng Wu, Weiming Tang, Ke Liang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	HIV COVID-19 inactivated vaccine booster dose antibody response T cell immunity
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1174379/full

Similar Items

Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
by: Shi Zou, et al.
Published: (2022-10-01)

Corrigendum: Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
by: Shi Zou, et al.
Published: (2024-09-01)

Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
by: Songjie Wu, et al.
Published: (2021-12-01)

Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
by: Songjie Wu, et al.
Published: (2023-01-01)

Correction: Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
by: Songjie Wu, et al.
Published: (2024-09-01)

Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
by: Shi Zou, et al.
Published: (2022-07-01)

Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China
by: Yuting Tan, et al.
Published: (2023-11-01)

Risk of SARS-CoV-2 Infection Among People Living With HIV in Wuhan, China
by: Mengmeng Wu, et al.
Published: (2022-04-01)

Corrigendum: Risk of SARS-CoV-2 infection among people living with HIV in Wuhan, China
by: Mengmeng Wu, et al.
Published: (2024-09-01)

Adverse pregnancy outcomes associated with antiretroviral therapy initiated before pregnancy and during pregnancy: a retrospective study in Hubei province, China
by: Yuting Tan, et al.
Published: (2023-05-01)

Correction: Humoral immune response to inactivated COVID-19 vaccination at the 3rd month among people living with HIV
by: Songjie Wu, et al.
Published: (2024-09-01)

Correction: Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
by: Shi Zou, et al.
Published: (2024-09-01)

Inactivated COVID-19 vaccine booster dose shortened the viral shedding time of patients infected with the Omicron variant BA.2
by: Jun Wu, et al.
Published: (2023-06-01)

People living with HIV with the Omicron variant infection have milder COVID-19 symptoms: results from a cross-sectional study
by: Yuting Tan, et al.
Published: (2024-08-01)

Phenotype and function of peripheral blood γδ T cells in HIV infection with tuberculosis
by: Shi Zou, et al.
Published: (2022-12-01)

Prevalence and associated factors with low birth weight among human immunodeficiency virus exposed infants between 2004 and 2021 in Hubei, China: a retrospective cohort study
by: Jinli Liu, et al.
Published: (2025-02-01)

The Role of CD4+CD8+ T Cells in HIV Infection With Tuberculosis
by: Shi Zou, et al.
Published: (2022-05-01)

Inactivated COVID-19 vaccination and SARS-CoV-2 infection among Chinese adults in the “living with COVID” era
by: Hongbiao Chen, et al.
Published: (2024-02-01)

Characterization of peripheral cytokine-secreting cells responses in HIV/TB co-infection
by: Yuting Tan, et al.
Published: (2023-07-01)

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV
by: Zhengchao Lv, et al.
Published: (2023-11-01)

COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China
by: Songjie Wu, et al.
Published: (2022-05-01)

People living with HIV easily lose their immune response to SARS-CoV-2: result from a cohort of COVID-19 cases in Wuhan, China
by: Yanbin Liu, et al.
Published: (2021-10-01)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
by: Xiaofeng He, et al.
Published: (2023-10-01)

Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3–9-month intervals following two-dose inactivated vaccine (CoronaVac)
by: Yuting Liao, et al.
Published: (2022-11-01)

Immunogenicity and safety of different combinations involving a third booster dose of SARS-CoV-2 inactivated vaccine, inactivated quadrivalent influenza vaccine, and 23-valent pneumococcal polysaccharide vaccine in adults aged ≥60 years: a phase 4, randomized, open-label study
by: Shuang Bai, et al.
Published: (2024-08-01)

Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial
by: Huan Zhou, et al.
Published: (2024-06-01)

Antibody response after a booster dose of BNT162B2mRNA and inactivated COVID-19 vaccine
by: Metin Yigit, et al.
Published: (2022-08-01)

Efficacy and Safety of a Booster Vaccination with Two Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: Results of a Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trial in Abu Dhabi
by: Nawal Al Kaabi, et al.
Published: (2023-01-01)

Microbiomes Detected by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing among HIV-Infected and Uninfected Patients with Pulmonary Infection
by: Yuting Tan, et al.
Published: (2023-08-01)

Frequency and functional profile of circulating TCRαβ+ double negative T cells in HIV/TB co-infection
by: Yuting Tan, et al.
Published: (2022-11-01)

Immune Persistence following Primary Immunization and the Immunogenicity and Safety of a Booster Dose of a Multidose Sabin Strain-Based Inactivated Polio Vaccine in Infants Aged 18 Months
by: Guangwei Feng, et al.
Published: (2024-01-01)

Effectiveness of Sinopharm’s BBIBP-CorV Booster Vaccination against COVID-19-Related Severe and Critical Cases and Deaths in Morocco during the Omicron Wave
by: Jihane Belayachi, et al.
Published: (2024-02-01)

Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19
by: Yifeng Luo, et al.
Published: (2023-06-01)

Willingness-to-pay for a booster dose of inactivated SARS-CoV-2 vaccine in Taizhou, China
by: Tao-Hsin Tung, et al.
Published: (2022-11-01)

The Effect of a Booster Dose mRNA Vaccine on COVID-19 Infection in Kidney Transplant Recipients after Inactivated or Viral Vector Vaccine Immunization
by: Sansanee Thotsiri, et al.
Published: (2022-10-01)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study
by: Zhi-Qiang Lin, et al.
Published: (2022-04-01)

Covid-19 Vaccine Booster Dose and The Indian Scenario: When We Will Have a Fully Immunized Population?
by: Amitesh Datta, et al.
Published: (2023-09-01)

Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine
by: Sitthichai Kanokudom, et al.
Published: (2022-01-01)

Blood microbiota in HIV-infected and HIV-uninfected patients with suspected sepsis detected by metagenomic next-generation sequencing
by: Qianhui Chen, et al.
Published: (2024-10-01)

Safety and Immunogenicity of a Booster Vaccination by CoronaVac or BNT162b2 in Previously Two-Dose Inactivated Virus Vaccinated Individuals with Negative Neutralizing Antibody
by: Kristi Tsz-Wan Lai, et al.
Published: (2022-04-01)